Form D · Retailing

Emerald Health Bioceuticals Inc.

San Diego, CA · CIK 0001713164

Offering snapshot reported Mar 19, 2020 · SEC filing

Reported sold
$52K
Offering amount: $5M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 3, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 19, 2020Initial$52,000No comparison5SEC filing
Aug 17, 2017Amendment$127,006$103,266vs Jul 27, 20178SEC filing
Jul 27, 2017Initial$23,740No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-363301

Source: Form D, filed Mar 19, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jade Beutler Executive
Jill Broadfoot Executive
Margaret Dalesamdro Director
Punit Dhillon Director
Dr. Avtar Dhillon Director, Executive
Tu Diep Executive
Jim Heppell Director
Gaetano Morello Director, Executive
Dr. Gaetano Morello Director
Elena Traistaru Executive

Issuer details

Industry: Retailing (See others in industry)

Address:
5910 Pacific Center Blvd, Suite 300
San Diego, CA, 92121